Ornispar

Ornispar

l-ornithine-l-aspartate

Manufacturer:

PT Novell

Distributor:

Prosweal Healthcare
Concise Prescribing Info
Contents
L-ornithine-L-aspartate
Indications/Uses
Hyperammonemia due to acute & chronic liver disease eg, liver cirrhosis, fatty liver, hepatitis; treatment of incipient disturbances of consciousness (pre-coma) or neurological complications (hepatic encephalopathy).
Dosage/Direction for Use
May be given up to 4 amp/day. Incipient clouding of consciousness (pre-coma) or clouding of consciousness (coma) Up to 8 amp in 24 hr, depending on the severity of the condition. Venous tolerability Should not exceed 6 amp/500 mL infusion. Max infusion rate: 5 g/hr.
Contraindications
Hypersensitivity. Severe renal impairment (renal failure); serum creatinine level in excess of 3 mg/100 mL.
Special Precautions
Monitor serum & urinary urea levels. Adjust infusion rate if liver function is substantially impaired. May impair ability to drive or operate machinery. Hepatic impairment. Pregnancy & lactation.
Adverse Reactions
Mild to moderate sensation of heat palpitation, nausea & vomiting.
ATC Classification
A05BA - Liver therapy ; Used in liver therapy.
Presentation/Packing
Form
Ornispar soln for infusion 500 mg/mL
Packing/Price
10 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in